Genexa Allergy Care
NDC 69676-0052, Allium cepa, Ambrosia artemisiifolia, Arundo mauritanica, Dulcamara, Euphrasia officinalis, Nux vomica, Pulsatilla, Ranunculus bulbosus, Sabadilla, Sinapis nigra, Sticta pulmonaria, Wyethia helenoides, tablet, chewable, from Genexa Inc..
- Product NDC
- 69676-0052
- Status
- Listed
- Labeler
- Genexa Inc.
- Dosage form
- TABLET, CHEWABLE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69676-0052 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- AMBROSIA ARTEMISIIFOLIA12 [hp_X]/1
- STRYCHNOS NUX-VOMICA SEED12 [hp_X]/1
- BLACK MUSTARD SEED12 [hp_X]/1
- LOBARIA PULMONARIA12 [hp_X]/1
- ARUNDO PLINIANA ROOT12 [hp_X]/1
- RANUNCULUS BULBOSUS WHOLE12 [hp_X]/1
- PULSATILLA PRATENSIS12 [hp_X]/1
- SCHOENOCAULON OFFICINALE SEED12 [hp_X]/1
- SOLANUM DULCAMARA TOP12 [hp_X]/1
- EUPHRASIA STRICTA12 [hp_X]/1
- WYETHIA HELENIOIDES ROOT12 [hp_X]/1
- ALLIUM CEPA WHOLE12 [hp_X]/1
Pharmacologic classes
Allergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Seed Storage Proteins [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69676-0052-1 | 69676005201 | 1 BOTTLE, PLASTIC in 1 CARTON (69676-0052-1) / 60 TABLET, CHEWABLE in 1 BOTTLE, PLASTIC |
| 69676-0052-3 | 69676005203 | 2 TABLET, CHEWABLE in 1 POUCH (69676-0052-3) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 69676-0052 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69676-0052 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69676-0052. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.